Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00217919 · ClinicalTrials.gov registry record · NA

Reducing Risk Factors in Peripheral Arterial Disease

A NA study of Cardiovascular Diseases and Peripheral Vascular Diseases, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
355
Enrollment target
2
Study locations

NCT00217919 is a NA study of Cardiovascular Diseases and Peripheral Vascular Diseases that has completed, run by Northwestern University. The registered enrollment target is 355 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00217919, a NA study of Cardiovascular Diseases and Peripheral Vascular Diseases, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
355 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to compare a health-counselor mediated telephone counseling intervention to usual care to reduce low density lipoprotein cholesterol (LDL-C) levels in patients with peripheral arterial disease (PAD).

Interventions

  • BEHAVIORAL Health-Counselor Mediated Telephone Counseling Intervention

Study Locations (2)

Illinois

  • Northwestern University, Feinberg School of Medicine - Chicago

Massachusetts

  • University of Massachusetts Medical School - Worcester

Trial Details

FieldValue
Enrollment Target 355 participants
Start Date 2006-02
Est. Completion 2009-11
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00217919

The ClinicalTrials.gov registry entry for NCT00217919 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 355 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Health-Counselor Mediated Telephone Counseling Intervention is the first listed.

NCT00217919 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00217919 about?

NCT00217919 is a clinical study titled "Reducing Risk Factors in Peripheral Arterial Disease". The purpose of this study is to compare a health-counselor mediated telephone counseling intervention to usual care to reduce low density lipoprotein cholesterol (LDL-C) levels in patients with peripheral arterial disease (PAD).

What is the current status of trial NCT00217919?

This trial is currently completed. It is a NA study. The enrollment target is 355 participants. The study started on 2006-02. Estimated completion is 2009-11.

What conditions does trial NCT00217919 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Peripheral Vascular Diseases.

What interventions are being tested in trial NCT00217919?

The interventions under investigation include: Health-Counselor Mediated Telephone Counseling Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00217919?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00217919 being conducted?

This trial has 2 study locations across Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.